Works by Wallentin, Lars


Results: 199
    1
    2
    3

    Lp-PLA<sub>2</sub>, scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease.

    Published in:
    PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204352
    By:
    • Manichaikul, Ani;
    • Wang, Xin-Qun;
    • Li, Li;
    • Erdmann, Jeanette;
    • Lettre, Guillaume;
    • Bis, Joshua C.;
    • Waterworth, Dawn;
    • Cushman, Mary;
    • Jenny, Nancy S.;
    • Post, Wendy S.;
    • Palmas, Walter;
    • Tsai, Michael Y.;
    • Wallentin, Lars;
    • White, Harvey;
    • Schunkert, Heribert;
    • O’Donnell, Christopher J.;
    • Herrington, David M.;
    • Rich, Stephen S.;
    • O’Donoghue, Michelle L.;
    • Rodriguez, Annabelle
    Publication type:
    Article
    4
    5
    6
    7

    Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.

    Published in:
    JAMA Network Open, 2020, v. 3, n. 9, p. e2015943, doi. 10.1001/jamanetworkopen.2020.15943
    By:
    • Hijazi, Ziad;
    • Oldgren, Jonas;
    • Lindbäck, Johan;
    • Alexander, John H.;
    • Alings, Marco;
    • De Caterina, Raffaele;
    • Eikelboom, John W.;
    • Ezekowitz, Michael D.;
    • Held, Claes;
    • Huber, Kurt;
    • Hylek, Elaine M.;
    • Granger, Christopher B.;
    • Lopes, Renato D.;
    • Vinereanu, Dragos;
    • Siegbahn, Agneta;
    • Wallentin, Lars
    Publication type:
    Article
    8
    9
    10
    11
    12

    Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.

    Published in:
    European Heart Journal, 2009, v. 30, n. 19, p. 2346, doi. 10.1093/eurheartj/ehp261
    By:
    • Lind, Lars;
    • Wallentin, Lars;
    • Kempf, Tibor;
    • Tapken, Heike;
    • Quint, Anja;
    • Lindahl, Bertil;
    • Olofsson, Sylvia;
    • Venge, Per;
    • Larsson, Anders;
    • Hulthe, Johannes;
    • Elmgren, Anders;
    • Wollert, Kai C.
    Publication type:
    Article
    13
    14
    15
    16
    17

    Anticoagulants in heart disease: current status and perspectives‡.

    Published in:
    European Heart Journal, 2007, v. 28, n. 7, p. 880, doi. 10.1093/eurheartj/ehl492
    By:
    • De Caterina, Raffaele;
    • Husted, Steen;
    • Wallentin, Lars;
    • Agnelli, Giancarlo;
    • Bachmann, Fedor;
    • Baigent, Colin;
    • Jespersen, Jørgen;
    • Kristensen, Steen Dalby;
    • Montalescot, Gilles;
    • Siegbahn, Agneta;
    • Verheugt, Freek W.A.;
    • Weitz, Jeffrey
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction—the ASSENT Plus study.

    Published in:
    European Heart Journal, 2003, v. 24, n. 10, p. 897, doi. 10.1016/S0195-668X(03)00006-X
    By:
    • Wallentin, Lars;
    • Bergstrand, Lott;
    • Dellborg, Mikael;
    • Fellenius, Carin;
    • Granger, Christopher B;
    • Lindahl, Bertil;
    • Lins, Lars-Eric;
    • Nilsson, Tage;
    • Pehrsson, Kenneth;
    • Siegbahn, Agneta;
    • Swahn, Eva
    Publication type:
    Article
    37
    38
    39
    40
    41
    42

    Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics.

    Published in:
    Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 549, doi. 10.1007/s10557-020-06988-w
    By:
    • Morales-Rosado, Joel A.;
    • Goel, Kashish;
    • Zhang, Lingxin;
    • Åkerblom, Axel;
    • Baheti, Saurabh;
    • Black, John L.;
    • Eriksson, Niclas;
    • Wallentin, Lars;
    • James, Stefan;
    • Storey, Robert F.;
    • Goodman, Shaun G.;
    • Jenkins, Gregory D.;
    • Eckloff, Bruce W.;
    • Bielinski, Suzette J.;
    • Sicotte, Hugues;
    • Johnson, Stephen;
    • Roger, Veronique L.;
    • Wang, Liewei;
    • Weinshilboum, Richard;
    • Klee, Eric W.
    Publication type:
    Article
    43
    44

    Interleukin‐18 in patients with acute coronary syndromes.

    Published in:
    Clinical Cardiology, 2019, v. 42, n. 12, p. 1202, doi. 10.1002/clc.23274
    By:
    • Åkerblom, Axel;
    • James, Stefan K.;
    • Lakic, Tatevik G.;
    • Becker, Richard C.;
    • Cannon, Christopher P.;
    • Steg, Philippe G.;
    • Himmelmann, Anders;
    • Katus, Hugo A.;
    • Storey, Robert F.;
    • Wallentin, Lars;
    • Weaver, W. Douglas;
    • Siegbahn, Agneta
    Publication type:
    Article
    45

    Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial.

    Published in:
    Clinical Cardiology, 2019, v. 42, n. 5, p. 568, doi. 10.1002/clc.23178
    By:
    • Guimarães, Patricia O.;
    • Pokorney, Sean D.;
    • Lopes, Renato D.;
    • Wojdyla, Daniel M.;
    • Gersh, Bernard J.;
    • Giczewska, Anna;
    • Carnicelli, Anthony;
    • Lewis, Basil S.;
    • Hanna, Michael;
    • Wallentin, Lars;
    • Vinereanu, Dragos;
    • Alexander, John H.;
    • Granger, Christopher B.
    Publication type:
    Article
    46

    Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial.

    Published in:
    Clinical Cardiology, 2017, v. 40, n. 6, p. 390, doi. 10.1002/clc.22733
    By:
    • Pollack, Charles V.;
    • Davoudi, Farideh;
    • Diercks, Deborah B.;
    • Becker, Richard C.;
    • James, Stefan K.;
    • Lim, Soo Teik;
    • Schulte, Phillip J.;
    • Spinar, Jindrich;
    • Steg, Philippe Gabriel;
    • Storey, Robert F.;
    • Himmelmann, Anders;
    • Wallentin, Lars;
    • Cannon, Christopher P.
    Publication type:
    Article
    47
    48
    49
    50